Home Newsfeeds EF Hutton Reiterates Buy on Adaptimmune Therapeutics, Maintains $10 Price Target

EF Hutton Reiterates Buy on Adaptimmune Therapeutics, Maintains $10 Price Target

EF Hutton analyst Tony Butler reiterates Adaptimmune Therapeutics (NASDAQ:ADAP) with a Buy and maintains $10 price target.

byBenzinga Newsdesk

March 6, 2023

1 minute read

EF Hutton analyst Tony Butler reiterates Adaptimmune Therapeutics (NASDAQ:ADAP) with a Buy and maintains $10 price target.

Keefe, Bruyette & Woods Maintains Market Perform on Progressive, Raises Price Target to $140

By Benzinga Newsdesk

February 17, 8:36 AM

Keefe, Bruyette & Woods analyst Meyer Shields maintains Progressive (NYSE:PGR) with a Market Perform and raises the price target from $127 to $140.

PGR

There’s Uncertainty Around Apple’s Patent Appeal For Watch, Masimo’s Royalty Exposure Is Priced In – Analyst Downgrades

By Vandana Singh

January 3, 2:30 PM

Needham downgraded Masimo Corporation (NASDAQ: MASI), noting that though Apple Inc (NASDAQ: AAPL) royalties are not certain, but are mostly priced into MASI shares.

AAPL

News

Why Marathon Petroleum Stock Hit A New 52-Week High Today

By Henry Khederian

September 18, 11:11 AM

Marathon Petroleum Corp (NYSE: MPC) shares are trading higher by 1.67% to $156.38 Monday morning.

MPC

Educational Developmen Announces Sale And Leaseback Agreement Of Headquarters And Warehouse Facility; Agreed Upon Sale Price Of The Hilti Complex Per The Executed Contract Totaled $35.5M

By Benzinga Newsdesk

June 12, 8:08 AM

Educational Development Corporation (NASDAQ:EDUC) ("EDC", the "Company" or "Seller") (http://www.edcpub.com) today announced that on June 6, 2024, it executed a Commercial Real Estate Contract ("Contract") with Rockford

EDUC

EF Hutton Reiterates Buy on Adaptimmune Therapeutics, Maintains $10 Price Target

Related Posts

Keefe, Bruyette & Woods Maintains Market Perform on Progressive, Raises Price Target to $140

There’s Uncertainty Around Apple’s Patent Appeal For Watch, Masimo’s Royalty Exposure Is Priced In – Analyst Downgrades

Why Marathon Petroleum Stock Hit A New 52-Week High Today

Educational Developmen Announces Sale And Leaseback Agreement Of Headquarters And Warehouse Facility; Agreed Upon Sale Price Of The Hilti Complex Per The Executed Contract Totaled $35.5M